Fasenra 30 MG/ML syringeml
Ended Awarded Last action
- Contract number
- SPE2DR26FQSU6
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $14,963
Award facts
- Contract value 100% obligated
- $14,962.50 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a $14,962.50 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for Fasenra 30 mg/ml syringes. The award, issued on December 2, 2025, with an ultimate completion date of December 3, 2025, carries no set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. DMS Pharmaceutical Group was selected as the awardee based on its established performance as a critical supplier within the federal pharmaceutical supply chain and its extensive experience distributing branded and generic pharmaceuticals, biologics, and medical consumables to Department of Defense facilities.
This delivery order is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract (IDC) with the DLA Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V), a $30.3 billion acquisition strategy designed to support recurring medical supply needs of military healthcare facilities worldwide. The parent IDC, awarded on November 13, 2025, carries a $500 million ceiling value and extends through December 31, 2036, with a 30-month base period followed by three 30-month option periods. Through this vehicle, DLA authorizes firm fixed-price delivery orders for comprehensive pharmaceutical products to support Department of Defense healthcare operations globally, positioning DMS Pharmaceutical Group as a regional prime vendor contractor within this strategic military medical supply framework.
Quick answers
Who was awarded contract SPE2DR26FQSU6?
SPE2DR26FQSU6 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on December 2, 2025.
How much is contract SPE2DR26FQSU6 worth?
The government has obligated $14,963 on SPE2DR26FQSU6.
Is contract SPE2DR26FQSU6 an order under another contract?
Yes. SPE2DR26FQSU6 is a delivery order under SPE2DR25D9214, an indefinite delivery contract.
Was contract SPE2DR26FQSU6 competed?
The extent of competition for SPE2DR26FQSU6 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award